Vitamin deficiencies still remain to be a major threat to the general wellbeing of people. Though required in a very small amount, they are the important elements to keep the body healthy. The deficiencies of vitamins in the body tend to cause mental confusion, nausea, irritability, muscle weakness, depression, constipation, and others. Important nutritional elements required by the body are vitamins E, D, C, zinc, selenium, and omega-3 fatty acids. They have well-developed immunomodulatory impacts and help fighting several infections in the body, including coronavirus.
The healthcare sector is working on lessening the issues occurring due vitamin deficiency. Over the past few years, the number of people suffering due to lack of vitamins is rising significantly all over the world. Moreover, increased cases of acute & chronic health issues, rising research & development activities, and increasing demand for vitamin D & B complex are some of the major factors driving the demand in the global vitamin deficiency treatment market.
Lack of vitamin D continues to emerge as a worldwide health issue, dealing with its deficiency need vigorous health awareness and interventions, comprising food fortification of vitamin D and treatment of its deficiency. The growth in the geriatric population across the world is another factor fueling the growth in the global vitamin deficiency treatment market, as this section of the population is more vulnerable and prone of vitamin deficiencies and thus is exposed to several diseases.
The global vitamin deficiency treatment market is segregated into product, route of administration, distribution channel, and region. The product segment is divided into over-the-counter multivitamin therapies, vitamin D supplements, single vitamin therapies, vitamin A supplements, vitamin C supplements, vitamin B supplements, and others. In terms of route of administration, the market is bifurcated into parental and oral. On the basis of distribution channels, the global market is sectioned into retail pharmacies, online pharmacies, and hospital pharmacies.
Geographically, the global vitamin deficiency treatment market is estimated to be led by Asia Pacific particularly in South East and South Asia. A large number of people in China suffer from rickets, a deformity of soft bones. This is caused due to lack of vitamin D. Additionally, rising income and awareness to spend more on healthcare, coupled with rising demand for nutrition-rich food are some of the major supporting factors behind the regional growth, uplifting the demand for high-nutrition products.
China and India are the two main countries contributing to the growth attributed to easy availability of manpower, raw materials, demand for healthy foods, and being leading producers of vitamin D products. Moreover, the countries have several key players as their base for pharmaceutical and manufacturing firms.
Some of the key players operating in the global vitamin deficiency treatment market are Cipla Inc., Merck & Co., Inc., Sun Pharmaceutical Industries Ltd, F. Hoffmann-La Roche Ltd, Pfizer Inc., Mankind Pharma, Sandoz International GmbH, Dabur International Limited, Pharmavite LLC., BASF SE, Himalaya Wellness, Reckitt Benckiser Group plc, Zhejiang Garden Biochemical High-Tech Co., Ltd, Glanbia plc, and DSM, etc. To cite, GlaxoSmithKline plc and Pfizer Inc. a while ago collaborated to develop a global consumer healthcare firm with leading brands.